ACell Expands MatriStem® Pelvic Floor Matrix Product Portfolio with Addition of Four Device Sizes


Offers broad range of regenerative therapy solutions

Offers broad range of regenerative therapy solutions
Columbia, MD – (February 3, 2014 ) – ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has expanded the MatriStem® Pelvic Floor Matrix product portfolio with the addition of four device sizes. The addition of four new sizes to the portfolio offers a broad range of viable solutions for physicians treating patients in need of pelvic floor repair.

MatriStem Pelvic Floor Matrix is a naturally-occuring, non-synthetic scaffold that provides a unique balance of strength and pliability for use in repair of anterior, posterior and apical defects. Comprised of proprietary Urinary Bladder Matrix (UBM), MatriStem Pelvic Floor Matrix is intended for implantation to reinforce soft tissue where weakness exists in urological and gynecological anatomy including vaginal prolapse repair, reconstruction of pelvic floor, and pubourethral support.

On the market since 2010, MatriStem Pelvic Floor Matrix is currently available in 9x9x12cm (trapezoid) size, with four new sizes being added to the product line: 5x5cm, 4x12cm, 7x10cm and 10x15cm. The full line of products available in five sizes were made available on January 10th, 2014.

Rodney Bosley, President of ACell, remarked, “ACell has extended the MatriStem Pelvic Floor Matrix product portfolio with the addition of four sizes to provide a series of viable options for physicians treating patients requiring pelvic floor repair. We have seen a growing demand by physicians for devices that promote the formation of site-specific tissue and restore form through constructive remodeling. Our goal continues to be improving the lives of patients through offering effective tissue repair products.”

MatriStem products are medical devices that maintain and support a healing environment through constructive remodeling. Composed of naturally-occurring urinary bladder matrix (UBM), MatriStem maintains an intact epithelial basement membrane and facilitates the body’s ability to form site specific tissue.

ACell, Inc. offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix products to repair and remodel damaged tissues in a broad range of applications. Its patented MatriStem ECM medical devices maintain and support a healing environment through constructive remodeling and are available in particle and sheet forms for the treatment of acute wounds and various surgical procedures. For more information, please visit www.acell.com.

About Acell

ACell, Inc. is a leading developer, manufacturer and marketer of next-generation regenerative medicine products. Its products are cleared for a variety of indications and are marketed under the brand name “MatriStem.” A privately held Company, Acell produces MatriStem in its manufacturing facilities and markets its products to physicians in the U.S. through a national direct sales force. For more information, call (800) 826-2926 or visit www.acell.com.

About MatriStem

MatriStem Products consist of porcine-derived extracellular matrix (ECM) that maintain and support a healing environment through constructive remodeling, and are available in particle and sheet forms by prescription only. These devices, trademarked as MatriStem, are appropriate for acute wounds, chronic wounds and various surgical procedures. All MatriStem devices are made in the USA. Refer to IFU supplied with each device for indications, contraindications, and precautions.

Download a PDF of this article

Return to News